Record ID | marc_openlibraries_sanfranciscopubliclibrary/sfpl_chq_2018_12_24_run04.mrc:313628682:3892 |
Source | marc_openlibraries_sanfranciscopubliclibrary |
Download Link | /show-records/marc_openlibraries_sanfranciscopubliclibrary/sfpl_chq_2018_12_24_run04.mrc:313628682:3892?format=raw |
LEADER: 03892cam a2200613 a 4500
001 814389713
003 OCoLC
005 20151005104958.0
008 121019r20132012nyua b 001 0 eng
010 $a2012038902
019 $a801928086$a823771100
020 $a9780865478008 (hbk. : alk. paper)
020 $a0865478007 (hbk. : alk. paper)
035 $a814389713
035 $a(OCoLC)814389713$z(OCoLC)801928086$z(OCoLC)823771100
037 $bFarrar Straus & Giroux, C/O Mps 16365 James Madison Hwy, Gordonsville, VA, USA, 22942, (540)6727600$nSAN 631-5011
040 $aDLC$beng$erda$cDLC$dIG#$dOCLCO$dUPZ$dYDXCP$dBTCTA$dBDX$dMLY$dIQ2$dWIM$dNSB$dMOF$dVP@$dBUR$dOHS$dSFR$dUtOrBLW
042 $apcc
049 $aSFRA
050 00 $aRM301.27$b.G65 2013
082 00 $a615.1072/4$223
092 $a615.1072$bG5639b 2013
100 1 $aGoldacre, Ben.
245 10 $aBad pharma :$bhow drug companies mislead doctors and harm patients /$cBen Goldacre.
250 $a1st American ed.
260 $aNew York :$bFaber and Faber,$c2013.
300 $axvii, 426 p. :$bill. ;$c22 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $a"Originally published in 2012 by Fourth Estate, Great Britain"--T.p. verso.
504 $aIncludes bibliographical references (p. 371-405) and index.
505 0 $aIntro -- Missing data -- Where do new drugs come from? -- Bad regulators -- Bad trials -- Bigger, simpler trials -- Marketing -- Afterword: better data.
520 $aWe like to imagine that medicine is based on evidence and the results of fair tests. In reality, those tests are often profoundly flawed. We like to imagine that doctors are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the pharmaceutical industry. We like to imagine that regulators let only effective drugs onto the market, when in reality they approve useless drugs, with data on side effects casually withheld from doctors and patients. All these problems have been shielded from public scrutiny because they're too complex to capture in a sound bite. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct on a global scale affects us. This book reveals a shockingly broken system and calls for something to be done.--From publisher description.
650 0 $aDrugs$xTesting.
650 0 $aDrugs$xTesting$xMoral and ethical aspects.
650 0 $aClinical trials$xMoral and ethical aspects.
650 0 $aPharmaceutical industry$xMoral and ethical aspects.
650 0 $aDrugs$xQuality control.
907 $a.b26083942$b12-20-18$c02-07-13
998 $ac2$a(2)xbt$b03-13-13$cm$da $e-$feng$gnyu$h0$i7
957 00 $aOCLC reclamation of 2017-18
907 $a.b26083942$b08-24-15$c02-07-13
938 $aIngram$bINGR$n9780865478008
938 $aYBP Library Services$bYANK$n9368994
938 $aBaker and Taylor$bBTCP$nBK0011799954
938 $aBrodart$bBROD$n103331069
956 $aPre-reclamation 001 value: ocn814389713
980 $a0313 sh
998 $ac2$ae9$ai5$axbt$am6$ar3$aw2$b03-13-13$cm$da$e-$feng$gnyu$h0$i7
994 $aC0$bSFR
999 $yMARS
945 $a615.1072$bG5639b 2013$d - - $e01-20-2015 14:13$f0$g0$h04-06-15$i31223094878916$j131$0800$k - - $lc2aaa$ol$p$28.00$q-$r-$s- $t0$u5$v5$w0$x0$y.i72988824$z04-12-13
945 $a615.1072$bG5639b 2013$d - - $e09-07-2018 15:38$f0$g0$h11-16-18$i31223102478832$j503$0800$k - - $lxbtci$o-$p$28.00$q-$r-$s- $t0$u8$v11$w1$x0$y.i72863274$z03-28-13